Masaru Taniguchi

Title: Masaru Taniguchi: Innovator in NKT Cell-Activating Agents

Introduction

Masaru Taniguchi is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of immunology, particularly in the development of NKT cell-activating agents. With a total of 3 patents to his name, Taniguchi's work has the potential to impact therapeutic approaches for various autoimmune diseases.

Latest Patents

Taniguchi's latest patents focus on NKT cell-activating agents that contain α-glycosylceramides. The objective of these inventions is to provide therapeutic agents for autoimmune diseases such as systemic lupus erythematosus, systemic sclerosis, ulcerative colitis, encephalomyelitis, multiple sclerosis, and human type I diabetes. The medicinal compositions he developed comprise α-glycosylceramides, or a salt or a solvate thereof, as an active ingredient. These innovations aim to enhance the treatment options available for patients suffering from these conditions.

Career Highlights

Throughout his career, Masaru Taniguchi has worked with notable companies, including Kirin Beer Company and Hoechst Japan Limited. His experience in these organizations has contributed to his expertise in the field of immunology and patent development.

Collaborations

Taniguchi has collaborated with esteemed colleagues such as Tetsu Kawano and Yasuhiko Koezuka. These partnerships have likely enriched his research and innovation efforts, leading to advancements in the field.

Conclusion

Masaru Taniguchi's contributions to the development of NKT cell-activating agents highlight his role as an influential inventor in the field of immunology. His work continues to pave the way for new therapeutic options for autoimmune diseases.